Turner Christopher Durant - Insider Non-Derivative Transactions at Nuvalent, Inc. (NUVL) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 5, 2024, Turner Christopher Durant's relationship to Nuvalent, Inc. (NUVL) is Officer (Chief Medical Officer), and currently has 47,813 shares of Class A Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other NUVL insiders.

Data Source: SEC.
Turner Christopher Durant - Insider Non-Derivative Transactions of NUVL Class A Common Stock
Turner Christopher Durant - Insider Non-Derivative Transactions at NUVL
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 6, 2024 Acquisition -- (Class A Common Stock) 33300 0 47813
Oct 5, 2023 Sell -- (Class A Common Stock) 1465 57.7 14513
Oct 5, 2023 Sell -- (Class A Common Stock) 500 57.18 15978
Oct 5, 2023 Sell -- (Class A Common Stock) 500 55.84 16478
Oct 5, 2023 Sell -- (Class A Common Stock) 600 54.32 16978
Oct 5, 2023 Sell -- (Class A Common Stock) 2265 53.7 17578
Oct 5, 2023 Sell -- (Class A Common Stock) 2665 51.32 19843
Oct 5, 2023 M -- (Class A Common Stock) 7995 6.89 22508
Jul 29, 2023 Sell -- (Class A Common Stock) 2665 48.93 14513
Jul 29, 2023 M -- (Class A Common Stock) 2665 6.89 17178
Jul 27, 2023 Sell -- (Class A Common Stock) 2365 46.85 14513
Jul 27, 2023 M -- (Class A Common Stock) 2365 6.89 16878
Jul 25, 2023 Sell -- (Class A Common Stock) 200 46.82 14513
Jul 25, 2023 M -- (Class A Common Stock) 200 6.89 14713
Jul 21, 2023 Sell -- (Class A Common Stock) 100 46.8 14513
Jul 21, 2023 M -- (Class A Common Stock) 100 6.89 14613
Jun 6, 2023 Sell -- (Class A Common Stock) 10235 44.86 14513
Jun 6, 2023 M -- (Class A Common Stock) 10235 6.89 24748